Medline Inc.

As of June 30, 2026, Medline, Inc. Class A carries a market capitalization of 29.82B, placing it among publicly traded companies globally. Its enterprise value stands at 45.11B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medline, Inc. Class A's next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, Medline, Inc. Class A has 877.00M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Medline, Inc. Class A maintains a current ratio of 4.33, meaning it holds 4.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Medline, Inc. Class A recorded 152.30M in income tax expense.

As of the close on October 22, 2026, Medline, Inc. Class A's stock has gained approximately 5577.66% over the past 52 weeks. The 50-day moving average sits at 30.06, while the 200-day moving average is 33.92.

As of June 30, 2026, Medline, Inc. Class A holds 2.34B in cash and equivalents against 11.06B in total debt, resulting in a net debt position of 8.97B. Total book value stands at 10.13B, with working capital of 7.91B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Medline, Inc. Class A paid dividends of 0.08 per share.

Medline, Inc. Class A's most recent stock split took place on December 22, 2025 with a 70:1 split ratio.